title: Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.
abstract: The introduction of Haemophilus influenzae type b (Hib) vaccine in developing countries has suffered from a long delay. Between 2005 and 2009, a surge in Hib vaccine adoption took place, particularly among GAVI-eligible countries. Several factors contributed to the increase in Hib vaccine adoption, including support provided by the Hib Initiative, a project funded by the GAVI Alliance in 2005 to accelerate evidence-informed decisions for use of Hib vaccine. This paper reviews the strategy adopted by the Hib Initiative and the lessons learned in the process, which provide a useful model to accelerate uptake of other new vaccines.
authors.affiliation: Division of Bacterial Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS C-25, Atlanta, GA 30333, USA. RHajjeh@cdc.gov, rfh5@cdc.gov
authors.forename: R A
authors.initials: RA
authors.lastname: Hajjeh
authors.forename: L
authors.initials: L
authors.lastname: Privor-Dumm
authors.forename: K
authors.initials: K
authors.lastname: Edmond
authors.forename: R
authors.initials: R
authors.lastname: O'Loughlin
authors.forename: S
authors.initials: S
authors.lastname: Shetty
authors.forename: U K
authors.initials: UK
authors.lastname: Griffiths
authors.forename: A P
authors.initials: AP
authors.lastname: Bear
authors.forename: A L
authors.initials: AL
authors.lastname: Cohen
authors.forename: A
authors.initials: A
authors.lastname: Chandran
authors.forename: A
authors.initials: A
authors.lastname: Schuchat
authors.forename: E K
authors.initials: EK
authors.lastname: Mulholland
authors.forename: M
authors.initials: M
authors.lastname: Santosham
mesh_terms: D016667:Bacterial Capsules / Q000008:administration & dosage*; D003906:Developing Countries; D006192:Haemophilus Infections / Q000517:prevention & control*; D018073:Haemophilus Vaccines / Q000008:administration & dosage*; D006801:Humans; D017589:Immunization Programs / Q000458:organization & administration*; D055818:Public-Private Sector Partnerships
chemical_list: D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine